Faron Pharmaceuticals
Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer
April 2, 2026Faron Pharmaceuticals
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …
Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer
December 3, 2025Faron Pharmaceuticals, chief financial officer
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as its new Chief Financial Officer (CFO). Dekkers most recently …
Faron reports increased remission rate in trial for myelodysplastic syndrome candidate
August 7, 2025Medical Communications, Research and Development Faron Pharmaceuticals, Oncology, US Food and Drug Administration, acute myeloid leukemia, myelodysplastic syndrome
Faron Pharmaceuticals has reported a rise in complete remission (CR) rates among patients with frontline high-risk myelodysplastic syndrome (HR-MDS) in …
US Department of Defense selects Faron for $6.1m COVID-19 research funding
January 18, 2021Sales and Marketing Faron Pharmaceuticals, US
The US Department of Defense (DoD) has selected Faron Pharmaceuticals’ HIBISCUS study to receive $6.1 million of funding from the …
Pharma manufacturing news in brief
January 21, 2011Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp
Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
